Table 1.

Demographics and clinical characteristics of hepatocyte/liver cohorts

	Hepatocyte Discovery Cohort		GTEx Liver Cohort	Innocenti Validation Liver Cohort
	RNA-Seq cohort	Methylation cohort
Variable	AA (n = 60)	AA (n = 44)	AA (n = 15)	AAa and EAb (n = 206)
Percentage of AA subjects (%)	100	100	100	11.1
Age, yearsc (mean ± SD)	39 ± 20.5	46 ± 12.2	54.5 ± 6.6	46 ± 22
Sex (female %)d	48.3	52.3	20	36.4
West Africane ancestry (%) (mean ± SD)	78.17 ± 12.86	79.83 ± 11.86	84.04 ± 7.13	NA

^aAA: African Americans >40% WAA

^bEA: European Americans with <1% WAA

^cp = 0.0280 for age (between groups, one-way ANOVA), p = 0.0409 (between RNA-Seq and GTEx Liver cohorts)

^dp = 0.0439 for sex

^ep = 0.2331 for ancestry